These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30478216)

  • 41. Creating consensus on coverage choices.
    Davis K; Schoen C
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-199-211. PubMed ID: 14527253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Framing incremental expansions to public health insurance systems: the case of Canadian pharmacare.
    Daw JR; Morgan SG; Collins PA; Abelson J
    J Health Polit Policy Law; 2014 Apr; 39(2):295-330. PubMed ID: 24711215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New federal guidelines: a green light from government.
    Gosselin RA
    Hosp Formul; 1978 Jul; 13(7):546-9. PubMed ID: 10308293
    [No Abstract]   [Full Text] [Related]  

  • 44. PHARMAC has no cost-effectiveness threshold.
    Metcalfe S; Rodgers A; Werner R; Schousboe C
    N Z Med J; 2012 Feb; 125(1350):99-101. PubMed ID: 22382263
    [No Abstract]   [Full Text] [Related]  

  • 45. A spending spree as Chrétien prepares to leave? Don't count on it.
    Kondro W
    CMAJ; 2002 Nov; 167(11):1280. PubMed ID: 12451099
    [No Abstract]   [Full Text] [Related]  

  • 46. Six Myths About Pharmacare.
    Lexchin J
    Health Law Can; 2017 Feb; 37(2-3):44-51. PubMed ID: 30005520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equity in health financing of Guangxi after China's universal health coverage: evidence based on health expenditure comparison in rural Guangxi Zhuang autonomous region from 2009 to 2013.
    Qin X; Luo H; Feng J; Li Y; Wei B; Feng Q
    Int J Equity Health; 2017 Sep; 16(1):174. PubMed ID: 28962656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MAC study confirms pharmacy losses.
    Torielli G; Gagnon JP; Lingle EW
    Am Pharm; 1982 Aug; NS22(8):31-3. PubMed ID: 6751062
    [No Abstract]   [Full Text] [Related]  

  • 49. Rumors rife on health changes.
    Hughes AD
    Aust Hosp; 1977 Aug; (11):2. PubMed ID: 10305996
    [No Abstract]   [Full Text] [Related]  

  • 50. An equitable way to pay for universal coverage.
    Rasell E
    Int J Health Serv; 1999; 29(1):179-88. PubMed ID: 10079403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Medicare prescription drug benefit: issues and options.
    Cubanski J
    Issue Brief (Commonw Fund); 2003 Apr; (618):1-8. PubMed ID: 12693394
    [No Abstract]   [Full Text] [Related]  

  • 52. Is universal coverage via social health insurance financially feasible in Swaziland?
    Mathauer I; Musango L; Sibandze S; Mthethwa K; Carrin G
    S Afr Med J; 2011 Mar; 101(3):179-83. PubMed ID: 21382249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SHIPS awarded 31.7 million dollars to help beneficiaries about new drug coverage.
    Miss RN; 2005; 67(2):17. PubMed ID: 16047853
    [No Abstract]   [Full Text] [Related]  

  • 54. Exploring the features of universal coverage.
    Carrin G; Xu K; Evans DB
    Bull World Health Organ; 2008 Nov; 86(11):818. PubMed ID: 19030678
    [No Abstract]   [Full Text] [Related]  

  • 55. Modelling the affordability and distributional implications of future health care financing options in South Africa.
    McIntyre D; Ataguba JE
    Health Policy Plan; 2012 Mar; 27 Suppl 1():i101-12. PubMed ID: 22388495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medicare's Evolution: National Pharmacare and Shared Leadership.
    Nemis-White J; Torr E; Aylen J; Gogovor A; Martin L; Mitchell J; MacPherson N; Montague T
    Healthc Q; 2019 Jul; 22(2):15-19. PubMed ID: 31556374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Universal health coverage and universal access.
    Evans DB; Hsu J; Boerma T
    Bull World Health Organ; 2013 Aug; 91(8):546-546A. PubMed ID: 23940398
    [No Abstract]   [Full Text] [Related]  

  • 58. Costing and funding of healthcare in Australia: pharmaceuticals in context.
    Parry TG
    Pharmacoeconomics; 1994 Mar; 5(3):180-7. PubMed ID: 10146893
    [No Abstract]   [Full Text] [Related]  

  • 59. Pricing and reimbursement of pharmaceuticals in Italy.
    Folino-Gallo P; Montilla S; Bruzzone M; Martini N
    Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Will HCFA jump NHI on outpatient drug coverage?
    Eastman M
    Am Pharm; 1978 Aug; 18(9):43. PubMed ID: 354364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.